title: [Thrombolysis in acute massive lung embolism].
abstract: Thrombolytic therapy of pulmonary embolism reduces total pulmonary resistance more rapidly than heparin alone. In massive pulmonary embolism this hemodynamic benefit usually outweighs the moderately increased bleeding risk if contra-indications are strictly observed. Practical dosage regimens for streptokinase and urokinase are proposed.
authors.affiliation: Gerinnungs- und Fibrinolyselaboratorium, Kantonsspital, Basel.
authors.forename: G A
authors.initials: GA
authors.lastname: Marbet
mesh_terms: D000208:Acute Disease; D000403:Airway Resistance; D001780:Blood Coagulation Tests; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000503:physiopathology; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Thrombolyse bei akuter massiver Lungenembolie.